Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LITTLE GREEN PHARMA LTD Capital/Financing Update 2021

Mar 7, 2021

65232_rns_2021-03-07_e68d44ca-262f-468c-a492-495134a0ee1f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

8 MARCH 2021

LGP COMPLETES SUCCESSFUL $5 MILLION SPP

ASX ANNOUNCEMENT

Little Green Pharma Ltd ( ASX: LGP , “ LGP ” or the “ Company ”) is pleased to confirm that its Share Purchase Plan (“ SPP ”) announced on 9 February 2021 closed oversubscribed on Wednesday 3 March 2021. Under the SPP, each eligible shareholder was entitled to subscribe up to $30,000 worth of ordinary shares in the Company at any issue price of $0.65.

The SPP was strongly supported by LGP’s existing shareholders, receiving applications in excess of the stated $5,000,000 maximum. Accordingly, the Company will scale back applications on the basis disclosed in its SPP offer booklet.

The issue date for SPP shares will be 11 March 2021 with an expected date of quotation on 12 March 2021. Holding statements will be dispatched to successful applicants and refunds of application money for scaled back applications processed on or about 18 March 2021.

==> picture [138 x 198] intentionally omitted <==

The Board would like to thank existing shareholders for their strong support of the SPP.

ENDS

BY ORDER OF THE BOARD

==> picture [93 x 27] intentionally omitted <==

____________

Alistair Warren

Company Secretary

For further information please contact: Alistair Warren Fleta Solomon Company Secretary Managing Director Little Green Pharma Little Green Pharma E : [email protected] E : [email protected] T : +61 8 6280 0050 M: +41 782 260 200

Head Office PO Box 690, West Perth WA 6872 | T + 61 8 6280 0050 | E [email protected] | littlegreenpharma.com